Scarica l'app Stockscreener
1.01
0.50%
0.005
Dopo l'orario di chiusura:
1.02
0.01
+0.99%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ADIL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.005
Aprire:
$1.01
Volume 24 ore:
29,149
Relative Volume:
0.24
Capitalizzazione di mercato:
$6.41M
Reddito:
-
Utile/perdita netta:
$-6.07M
Rapporto P/E:
-0.134
EPS:
-7.54
Flusso di cassa netto:
$-7.34M
1 W Prestazione:
-0.98%
1M Prestazione:
+4.01%
6M Prestazione:
-40.59%
1 anno Prestazione:
-56.47%
Intervallo 1D:
$0.9922
$1.02
Intervallo di 1 settimana:
$0.9753
$1.02
Portata 52W:
$0.765
$4.1699
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Nome
Adial Pharmaceuticals Inc
Settore
Industria
Telefono
434-422-9800
Indirizzo
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-10-30 | Iniziato | Maxim Group | Buy |
| 2018-10-11 | Iniziato | Dawson James | Buy |
Adial Pharmaceuticals Inc Borsa (ADIL) Ultime notizie
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer - citybiz
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference - The Manila Times
EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate - AOL
Adial Pharmaceuticals patent expands for alcohol disorder drug - Investing.com
Adial Pharmaceuticals patent expands for alcohol disorder drug By Investing.com - Investing.com Canada
Adial Pharmaceuticals Receives Notice of Allowance for U.S. - GlobeNewswire
Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery - GlobeNewswire
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 46.2% in September - Defense World
Analyzing ADI’s price-to-book ratio for the last quarter - US Post News
Adial Pharmaceuticals completes key study stage for AUD drug - Investing.com
Adial Pharmaceuticals Announces Database Lock in - GlobeNewswire
Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder - StockTitan
Analog Devices Inc. (ADI) Stock: A Year of Declines and Increases - The InvestChronicle
MQS Management LLC Increases Stock Position in Analog Devices, Inc. (NASDAQ:ADI) - Defense World
Addex Therapeutics Reports Profitable H1 2024 - TipRanks
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - GlobeNewswire
Recent Insider Activity Could Benefit Adaptimmune Therapeutics Plc ADR (ADAP) - Knox Daily
ADMA Biologics stock soars to all-time high of $19.36 - Investing.com
ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Yahoo Finance
Adial Pharmaceuticals (NASDAQ:ADIL) versus Galapagos (NASDAQ:GLPG) Head-To-Head Comparison - Defense World
Analog Devices (NASDAQ:ADI) shareholders notch a 17% CAGR over 5 years, yet earnings have been shrinking - Yahoo Finance
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Eagle-Tribune
ADM Investor Services Singapore Becomes Abaxx Exchange's Third Clearing and Trading Member - GlobeNewswire
Raymond James lifts Adma Biologics Inc [ADMA] price estimate. Who else is bullish? - The DBT News
Keeping an Eye on Adma Biologics Inc (ADMA) After Insider Trading Activity - Knox Daily
Adma Biologics Inc (NASDAQ:ADMA) stock crossing the finish line today - US Post News
Analytical Overview: Adma Biologics Inc (ADMA)’s Ratios Tell a Financial Story - The Dwinnex
A new trading data show Adaptimmune Therapeutics Plc ADR (ADAP) is showing positive returns. - SETE News
ADIA Nutrition Stakes Claim in $6.7B Industry with Strategic Trademark Expansion - Marketscreener.com
ADMA Biologics set to join S&P SmallCap 600 index By Investing.com - Investing.com Canada
Take off with Applied Dna Sciences Inc (APDN): Get ready for trading - SETE News
ADMA Biologics Set to Join S&P SmallCap 600 Index - Yahoo Finance
Adma Biologics Inc (ADMA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Adma Biologics Inc (ADMA) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Predicting Adaptimmune Therapeutics Plc ADR’s (ADAP) earnings for the current quarter - US Post News
Balance Sheet Insights: Applied Dna Sciences Inc (APDN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
The Attractiveness of Investing In Analog Devices Inc. (ADI) is Growing - Knox Daily
Applied Dna Sciences Inc (APDN) is a good investment, but the stock may be undervalued - US Post News
Applied Dna Sciences Inc: Navigating Market Fluctuations with a 14.11M Market Cap - The InvestChronicle
Small-cap stars are buying this forecast-smashing biotech - Citywire New Model Adviser
Q2 2026 EPS Estimates for Analog Devices, Inc. Decreased by Analyst (NASDAQ:ADI) - MarketBeat
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Declines By 14.5% - Defense World
Analog Devices (NASDAQ:ADI) shareholders notch a 16% CAGR over 5 years, yet earnings have been shrinking - Simply Wall St
ADMA Shares Experience Surge in Value - Knox Daily
Analog Devices Inc. (ADI) did well last session? - US Post News
Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Increases By 8.3% - Defense World
Reviewing Adial Pharmaceuticals (NASDAQ:ADIL) and Ultragenyx Pharmaceutical (NASDAQ:RARE) - Defense World
EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder - MSN
Brookline Capital Management Research Analysts Cut Earnings Estimates for Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) - Defense World
Thinking about buying stock in Rivian Automotive, Joby Aviation, - GuruFocus.com
Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):